On ECHEMI
Home > Drugs > Shanghai Shyndec Pharmaceutical Co., Ltd.
Shanghai Shyndec Pharmaceutical Co., Ltd.
  • Founded in:

    1996-11-27
  • Country:

    China China
  • Address:

    No. 378, Jianlu Road, Pudong New Area, Shanghai
  • Tax NO.:

    91310000630459924R
  • Registered Funds:

    1,341,172,692 yuan
  • Website:

  • Email:

Related Drugs
Enalapril Maleate Tablets
Enalapril Maleate
Name Description Content CAS NO. Registered Holders
Enalapril maleate

Angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on dinephrogenic hypertension, mononephrogenic hypertension and spontaneous hypertension rat models.

More

Angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on dinephrogenic hypertension, mononephrogenic hypertension and spontaneous hypertension rat models.

76095-16-4 35
Milnacipran Hydrochloride Tablets
Milnacipran Hydrochloride
Name Description Content CAS NO. Registered Holders
(1R,2S)-rel-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide hydrochloride

Extract from the above information

More

Extract from the above information

101152-94-7 23
Centella asiatica tablets
Total glucosides of Centella asiatica.
Name Description Content CAS NO. Registered Holders
Clotrimazole

23593-75-1 46
Centella asiatica tablets
The main ingredient is Centella asiatica total glucosides.
Name Description Content CAS NO. Registered Holders
Clotrimazole

23593-75-1 46
Compound retinoic acid gel
This product is a compound preparation, its components are retinoic acid 0.025% and erythromycin 4%.
Name Description Content CAS NO. Registered Holders
Retinoic acid

Regulate abnormal keratinization of hair follicles, promote the separation and shedding of keratinocytes, enhance the mitotic activity of hair follicle epithelium, regulate the proliferation and differentiation of epidermal cells, improve excessive pigmentation caused by light damage, correct or prevent the effects of physiological aging, light radiation, etc. on dermal connective tissue.

More

Regulate abnormal keratinization of hair follicles, promote the separation and shedding of keratinocytes, enhance the mitotic activity of hair follicle epithelium, regulate the proliferation and differentiation of epidermal cells, improve excessive pigmentation caused by light damage, correct or prevent the effects of physiological aging, light radiation, etc. on dermal connective tissue.

0.025% 302-79-4 12
Erythromycin

It inhibits bacterial protein synthesis by reversibly binding to the 50S subunit of the ribosome of susceptible bacteria, has an antibacterial effect, and has a bactericidal effect on certain bacteria at high concentrations.

More

It inhibits bacterial protein synthesis by reversibly binding to the 50S subunit of the ribosome of susceptible bacteria, has an antibacterial effect, and has a bactericidal effect on certain bacteria at high concentrations.

4% 114-07-8 43
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.